It’s that time of year again when I grade my previous year’s predictions for the stem cell & regenerative medicine space. Overall, I did better than a typical year. I give the 2022 predictions an A- overall. This exercise can be kind of fun but also humbling. For example, I tend to be too optimistic […]
Grading my 2022 regenerative medicine predictions Read More »
I recently wrote about stem cell-related ideas for anti-aging and even cheating death, but there are of course other approaches including drugs like metformin. A new article outlines a massive research funding plan to tackle aging. Let’s start with that. Recommend reads including anti-aging Saudi Arabia plans to spend $1 billion a year discovering treatments to
Weekly reads: $1B Saudi anti-aging push, OCT4 necklace, cancer trial wows, coffee brain Read More »
The FDA has been busy with the COVID pandemic but it has many other things on its plate as well including cell therapies. Today I’m sharing some recent agency news and brief perspectives on it. FDA focus on clinic-related umbilical cord cell drug makers The agency warned an Idaho company that produces and sells umbilical
FDA news: warning letter pattern, cancer moonshot, CAR-T & gene-editing guidance Read More »
I’m taking a short break today from working on a big grant to put out this weekly reads post including on Sox transcription factors, cord blood paper controversy, and other interesting papers such as one on CTCF and chromatin domains after mitosis that really struck me. I can actually see blue sky today here in
Weekly reads: CTCF, Sox transcription factors, Clinic fires back, more Read More »
When my wife and I were expecting our first daughter way back in the nineties, we received a paper pamphlet about cord blood banking. Back then, I was a graduate student at UC San Diego School of Medicine working toward my Ph.D. in Molecular Pathology and my wife was in medical school at the time
Fact-checking, pros and cons of cord blood banking Read More »
Anyone with a seemingly only semi-functional nervous system now post-election might be turning to science to help their brains bounce back. Here are some of the things I’ve been reading or hope to soon. In good news for the stem cell and regenerative medicine field, especially here in California, it looks like us California voters
More states have taken action against stem cell clinic-related firms in the past year than ever before and now we can add Georgia to the list. Georgia adds to growing list of state AGs suing stem cell clinics The George Attorney General Chris Carr filed suit against several related firms (going by various names over
Georgia AG sues clinics & owner Justin Paulk Read More »
Here are our weekly recommended regenerative medicine and other notable science reads including a few things on COVID. It’s been quite an interesting week. “Junk DNA” is not so junky, role in differentiation NIH scientists showed how ancient retroviral genes, or “junk DNA”, may play a role in helping stem cells decide to become neurons. This
Weekly reads: ‘junk DNA’, COVID chaos, CRISPR CasΦ, & postdoc opps, more Read More »
Every now and then I collect a bunch of recent science good news that I’ve come across. Here are some past ‘good news’ posts. Today’s post includes such a recent collection and some funny stuff too at the end. Enjoy! BTW, science is not necessarily all about stem cells, right? Talk about good news. 1,000th
Good news science digest: HIV, brain, CRISPR, cats vs. dogs, space, & more Read More »
Today an opinion piece that I wrote about CIRM was published in the San Francisco Chronicle. The unusual element here is that the article is critical of CIRM. More specifically I raised concerns about a recent political trend at CIRM under its new President Randy Mills lobbying for dramatically weaker stem cell regulatory oversight. The Chronicle piece was first posted
The backstory on my opinion piece in SF Chronicle critical of CIRM lobbying Read More »